And board member Rachel David was for many years the director of policy & government affairs for Johnson & Johnson in Australia, one of the biggest pharma and med tech commercialisers in the world. She knows her way around Canberra and the TGA, as well as how to build strong commercial partnerships - that’s J&J bread and butter.
RHY Price at posting:
$1.03 Sentiment: None Disclosure: Held
